Puma Biotechnology Inc
Organization details
- Legal name
- Puma Biotechnology Inc
- Former names
- Innovative Acquisitions Corp
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- LOS Angeles
- Headquarters state / province
- California
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- PBYI
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001401667
- EIN
- 77-0683487
- Wikidata ID
- Q28877490
Board of directors
-
Adrian Senderowicz · DirectorSince 2023
-
Alan H. Auerbach · Director · President and CEOSince 2023
-
Alessandra Cesano · DirectorSince 2023
-
Allison Dorval · DirectorSince 2023
-
Brian M. Stuglik · DirectorSince 2023
-
Jay M. Moyes · DirectorSince 2023
-
Michael Patrick Miller · DirectorSince 2023
-
Troy Edward Wilson · DirectorSince 2023
Chief executives
Director election results
Annual meeting of June 11, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
85.8%
-
96.5%
-
97.9%
-
98.2%
-
98.2%
-
98.6%
-
98.8%
-
98.8%
Board connections
7 of this board's directors also sit on 10 other boards. 10 are in the same sector.
-
Anavex Life Sciences Corp. Same sectorvia Adrian Senderowicz
-
Atrium Therapeutics Inc. Same sectorvia Troy Edward Wilson
-
BioCardia Inc. Same sectorvia Jay M. Moyes
-
Jade Biosciences Inc. Same sectorvia Allison Dorval
-
Kura Oncology Inc. Same sectorvia Troy Edward Wilson
-
Rigel Pharmaceuticals Inc. Same sectorvia Michael Patrick Miller
-
SiNtx Technologies Inc. Same sectorvia Jay M. Moyes
-
Summit Therapeutics Inc. Same sectorvia Alessandra Cesano
-
Verastem Inc. Same sectorvia Brian M. Stuglik
-
Zymeworks Inc. Same sectorvia Alessandra Cesano
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $2,018,235
- 16 sales by 9 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 14, 2026 | Alessandra Cesano Director | Option exercise | +50,000 | $2.93 | $146,500 |
| Sep 14, 2026 | Troy Edward Wilson Director | Open-market sale | −5,000 | $9.10 | $45,500 |
| Sep 14, 2026 | Alessandra Cesano Director | Open-market sale | −62,150 | $9.12 | $566,808 |
| Jul 6, 2026 | Alan H. Auerbach Director, Officer (President and CEO), 10% owner | Open-market sale | −44,058 | $8.26 | $363,919 |
| Jul 6, 2026 | HUNT DOUGLAS M Officer (See Remarks) | Open-market sale | −8,460 | $8.26 | $69,880 |
| Jul 6, 2026 | NOUGUES MAXIMO F Officer (Chief Financial Officer) | Open-market sale | −9,386 | $8.26 | $77,528 |
| Jun 12, 2026 | Troy Edward Wilson Director | Open-market sale | −10,800 | $7.20 | $77,760 |
| Jun 12, 2026 | Brian M. Stuglik Director | Open-market sale | −8,100 | $7.20 | $58,320 |
| Jun 12, 2026 | Adrian Senderowicz Director | Open-market sale | −27,000 | $7.20 | $194,400 |
| Jun 12, 2026 | Jay M. Moyes Director | Open-market sale | −22,000 | $7.22 | $158,840 |
| Jun 12, 2026 | Allison Dorval Director | Open-market sale | −11,610 | $7.20 | $83,592 |
| Jun 11, 2026 | Troy Edward Wilson Director | Grant or award | +27,000 | — | — |
| Jun 11, 2026 | Brian M. Stuglik Director | Grant or award | +27,000 | — | — |
| Jun 11, 2026 | Adrian Senderowicz Director | Grant or award | +27,000 | — | — |
| Jun 11, 2026 | Michael Patrick Miller Director | Grant or award | +27,000 | — | — |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Puma Biotechnology Inc
Who is the CEO of Puma Biotechnology Inc?
Alan H. Auerbach is Puma Biotechnology Inc's President and CEO.
How many directors are on Puma Biotechnology Inc's board?
Puma Biotechnology Inc's board has 8 directors: Adrian Senderowicz, Alan H. Auerbach, Alessandra Cesano, Allison Dorval, Brian M. Stuglik, Jay M. Moyes, Michael Patrick Miller and Troy Edward Wilson.
Are Puma Biotechnology Inc insiders buying or selling shares?
Over the last 12 months, Puma Biotechnology Inc insiders made no open-market purchases and sold $2.0 million of shares in 16 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="puma-biotechnology-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.